絞り込み

16636

広告

スターを付ける スターを付ける     (26view , 0users)

Full Text Sources

Given the widespread practice of recommending drug holidays, we reviewed the impact of medication discontinuation of two common anti-osteoporosis therapies (bisphosphonates and denosumab). Trial evidence suggests the risk of new clinical fractures, and vertebral fracture increases when osteoporosis treatment with bisphosphonates or denosumab is stopped.
PMID: 31175404 [PubMed - as supplied by publisher]
印刷用ページを開く Endnote用テキストダウンロード